Dynamics of pneumococcal carriage among day-care center attendees during the transition from the 7-valent to the higher-valent pneumococcal conjugate vaccines in GreeceGRIVEA, Ioanna N; PRIFTIS, Kostas N; GIOTAS, Apostolos et al.Vaccine. 2014, Vol 32, Num 48, pp 6513-6520, issn 0264-410X, 8 p.Article

Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccineRUSSELL, F. M; BALLOCH, A; BYRNES, G. B et al.Vaccine. 2009, Vol 27, Num 41, pp 5685-5691, issn 0264-410X, 7 p.Article

Indirect effect of conjugate pneumococcal vaccination in a 2 + 1 dose scheduleVESTRHEIM, Didrik F; HØIBY, E. Arne; BERGSAKER, Marianne R et al.Vaccine. 2010, Vol 28, Num 10, pp 2214-2221, issn 0264-410X, 8 p.Article

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infantsGRIMPREL, E; LAUDAT, F; PATTERSON, S et al.Vaccine. 2011, Vol 29, Num 52, pp 9675-9683, issn 0264-410X, 9 p.Article

Impact of a single dose of the 7-valent pneumococcal conjugate vaccine on colonizationFRAZAO, Nelson; SA-LEAO, Raquel; DE LENCASTRE, Hermínia et al.Vaccine. 2010, Vol 28, Num 19, pp 3445-3452, issn 0264-410X, 8 p.Article

Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of ageGREENBERG, Richard N; GURTMAN, Alejandra; FRENCK, Robert W et al.Vaccine. 2014, Vol 32, Num 20, pp 2364-2374, issn 0264-410X, 11 p.Article

Immunogenicity and serotype-specific efficacy of a 9-valent pneumococcal conjugate vaccine (PCV-9) determined during an efficacy trial in The GambiaSAAKA, M; OKOKO, B. J; GOLDBLATT, D et al.Vaccine. 2008, Vol 26, Num 29-30, pp 3719-3726, issn 0264-410X, 8 p.Article

Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccineWUORIMAA, Tomi K; DAGAN, Ron; BAILLEUX, Fabrice et al.Vaccine. 2005, Vol 23, Num 46-47, pp 5328-5332, issn 0264-410X, 5 p.Article

Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects : Nasopharyngeal Carriage in the Pneumococcal Vaccine Licensure ProcessDAVIS, Stephanie M; DELORIA-KNOLL, Maria; KASSA, Hilina T et al.Vaccine. 2013, Vol 32, Num 1, pp 133-145, issn 0264-410X, 13 p.Article

Safety and immunogenicity of a 7-valent pneumococcal conjugate vaccine (Prevenar™) : Primary dosing series in healthy Chinese infantsRONG CHENG LI; FENG XIANG LI; YAN PING LI et al.Vaccine. 2008, Vol 26, Num 18, pp 2260-2269, issn 0264-410X, 10 p.Article

Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young childrenTOCHEVA, Anna S; JEFFERIES, Johanna M. C; RUBERY, Henry et al.Vaccine. 2011, Vol 29, Num 26, pp 4400-4404, issn 0264-410X, 5 p.Article

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?HANQUET, Germaine; PERROCHEAU, Anne; DE GREEFF, Sabine C et al.Vaccine. 2010, Vol 28, Num 23, pp 3920-3928, issn 0264-410X, 9 p.Article

Safety and immunogenicity of two octavalent pneumococcal conjugate vaccines in American Indian infantsEICK, Angelia; CROLL, Janné; WEATHERHOLTZ, Robert et al.Vaccine. 2004, Vol 22, Num 9-10, pp 1260-1264, issn 0264-410X, 5 p.Article

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccineJACKSON, Lisa A; GURTMAN, Alejandra; RICE, Kathryn et al.Vaccine. 2013, Vol 31, Num 35, pp 3585-3593, issn 0264-410X, 9 p.Article

The pharmacoeconomics of pneumococcal conjugate vaccines in Latin AmericaGIGLIO, Norberto; MICONE, Paula; GENTILE, Angela et al.Vaccine. Supplement. 2011, Vol 29, Num 3, issn 1359-5938, C35-C42Article

Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccinesWYSOCLCI, J; TANSEY, S; BRACHET, E et al.Vaccine. 2010, Vol 28, Num 49, pp 7779-7786, issn 0264-410X, 8 p.Article

B cell mediated priming following pneumococcal colonizationRABQUER, Bradley; SHRINER, Anne K; SMITHSON, S. Louise et al.Vaccine. 2007, Vol 25, Num 11, pp 2036-2042, issn 0264-410X, 7 p.Article

Salivary antibodies induced by the seven-valent PncCRM conjugate vaccine in the Finnish Otitis Media Vaccine TrialNURKKA, Anu; LAHDENKARI, Mika; PALMU, Arto et al.Vaccine. 2004, Vol 23, Num 3, pp 298-304, issn 0264-410X, 7 p.Article

Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing scheduleRODGERS, Gail L; ESPOSITO, Susanna; THOMPSON, Allison et al.Vaccine. 2013, Vol 31, Num 42, pp 4765-4774, issn 0264-410X, 10 p.Article

Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell toleranceVAN DEN BIGGELAAR, Anita H. J; POMAT, William; BOSCO, Anthony et al.Vaccine. 2011, Vol 29, Num 33, pp 5414-5420, issn 0264-410X, 7 p.Article

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infantsRUGGEBERG, Jens U; COLLINS, Clare; MARTIN, Sarah et al.Vaccine. 2007, Vol 25, Num 2, pp 264-271, issn 0264-410X, 8 p.Article

Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccineJACKSON, Lisa A; NEUZIL, Kathleen M; BAGGS, James et al.Vaccine. 2007, Vol 25, Num 20, pp 4029-4037, issn 0264-410X, 9 p.Article

Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infantsESPOSITO, Susanna; PUGNI, Lorenza; BOSIS, Samantha et al.Vaccine. 2005, Vol 23, Num 14, pp 1703-1708, issn 0264-410X, 6 p.Article

Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and olderJACKSON, Lisa A; GURTMAN, Alejandra; VAN CLEEFF, Martin et al.Vaccine. 2013, Vol 31, Num 35, pp 3594-3602, issn 0264-410X, 9 p.Article

Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in childrenFU TSENG, Hung; SY, Lina S; NALEWAY, Allison et al.Vaccine. 2013, Vol 31, Num 22, pp 2578-2583, issn 0264-410X, 6 p.Article